MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $19,696,000 | +109.6% | 375,300 | +32.9% | 0.01% | +83.3% |
| Q2 2020 | $9,395,000 | +36.9% | 282,379 | +11.9% | 0.01% | +20.0% |
| Q1 2020 | $6,861,000 | +113.1% | 252,259 | +54.6% | 0.01% | +150.0% |
| Q4 2019 | $3,219,000 | +55.5% | 163,139 | +2.2% | 0.00% | +100.0% |
| Q3 2019 | $2,070,000 | -6.8% | 159,696 | -10.4% | 0.00% | 0.0% |
| Q2 2019 | $2,220,000 | +10.6% | 178,296 | +29.0% | 0.00% | 0.0% |
| Q1 2019 | $2,008,000 | +43.9% | 138,196 | +9.3% | 0.00% | 0.0% |
| Q4 2018 | $1,395,000 | -58.0% | 126,396 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $3,324,000 | +28.6% | 126,396 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,585,000 | +28.9% | 126,396 | +14.4% | 0.00% | +100.0% |
| Q1 2018 | $2,005,000 | +31.5% | 110,487 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $1,525,000 | -24.6% | 109,296 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $2,022,000 | +9.5% | 109,296 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,847,000 | +51.3% | 109,296 | +19.5% | 0.00% | 0.0% |
| Q1 2017 | $1,221,000 | -16.5% | 91,496 | -5.9% | 0.00% | 0.0% |
| Q4 2016 | $1,463,000 | +28.8% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,136,000 | +8.2% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,050,000 | +16.9% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $898,000 | -37.7% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,442,000 | -9.6% | 97,196 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,595,000 | -27.6% | 97,196 | +0.6% | 0.00% | -50.0% |
| Q2 2015 | $2,204,000 | +78.0% | 96,636 | +18.7% | 0.00% | +100.0% |
| Q1 2015 | $1,238,000 | +26.3% | 81,436 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $980,000 | +6.2% | 81,436 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $923,000 | -10.0% | 81,436 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $1,025,000 | -85.2% | 84,836 | -85.7% | 0.00% | -83.3% |
| Q1 2014 | $6,934,000 | -67.0% | 595,215 | -50.0% | 0.01% | -68.4% |
| Q4 2013 | $21,041,000 | +18.1% | 1,190,120 | -3.8% | 0.02% | +5.6% |
| Q3 2013 | $17,811,000 | +751.0% | 1,237,768 | +790.7% | 0.02% | +800.0% |
| Q2 2013 | $2,093,000 | – | 138,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |